Studies of New Fused Benzazepine as Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

By Liu Jing   Li Yan   Zhang Shuwei   Xiao Zhengtao   Ai Chunzhi  

International Journal of Molecular Sciences, Vol. 12, Iss. 2, 2011-02 ,pp. : 1196-1221

MDPI

Access to resources Recommend Favorite

Evidence That Calmodulin Binding to the Dopamine D2 Receptor Enhances Receptor Signaling

By Liu Yong   Buck David   Macey Tara   Lan Hongxiang   Neve Kim  

Journal of Receptors and Signal Transduction, Vol. 27, Iss. 1, 2007-01 ,pp. : 47-65

Informa Healthcare

Access to resources Recommend Favorite

In vitro Binding and Functional Studies of Ac-RYYRIK-ol and Its Derivatives, Novel Partial Agonists of the Nociceptin/Orphanin F/Q Receptor

By  

Neurosignals, Vol. 15, Iss. 2, 2006-07 ,pp. : 91-101

Karger

Access to resources Recommend Favorite

Evaluation of (‐)‐[¹⁸F]Flubatine‐specific binding: Implications for reference region approaches

By  

SYNAPSE (ELECTRONIC), Vol. 72, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]‐(+)‐PHNO and [11C]raclopride positron emission tomography imaging study

By  

HUMAN BRAIN MAPPING, Vol. 36, Iss. 7, 2015-07 ,pp. : 2592-2601

John Wiley & Sons Inc

Access to resources Recommend Favorite